USPTO To Launch Cancer Moonshot Expedited Examination Pilot … – Mondaq News Alerts
USPTO To Launch Cancer Moonshot Expedited Examination Pilot … Mondaq News Alerts Source link
Read moreTag Archives: Cancer
Research Explores Link Between Cancer Survivors' Smoking … – Mirage News
Smoking and Oral Cancer – Daijiworld.com
How to deal with cancer recurrence – ETHealthWorld
Prehabilitation Prior to Breast Cancer Treatment
Researchers investigated whether prehabilitation could yield improvements in physical and psychological wellbeing prior to treatment in women with breast cancer. After systematic review, they concluded that prehabilitation interventions should be implemented in patients diagnosed with breast cancer given the potential improvements they yield. The study’s findings were published in Breast Cancer Research and Therapy. The systematic review was conducted under Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 14 studies on prehabilitation in patients with breast cancer, 7 randomized controlled trials, 5 quantitative […]
Read moreDogs’ Keen Sense of Smell May Help Them ‘See’ – Consumer Health News
THURSDAY, July 21, 2022 (HealthDay News) — While humans typically use their sight to orient themselves, dogs navigate the world by combining their sense of smell with their vision. So claims a new study that found dogs’ sense of smell is integrated with their vision and other unique parts of their brain. “We’ve never seen this connection between the nose and the occipital lobe, functionally the visual cortex in dogs, in any species,” said senior study author Pip Johnson, an assistant professor of clinical sciences at Cornell […]
Read moreIntegrating sequential immunotherapy to lung cancer treatment plans
June 24, 2022 1 min watch Source/Disclosures Published by: Source: Healio Interviews Disclosures: Marmarelis reports holding stock and other ownership interests in Bluebird Bio, Gilead Sciences, Johnson & Johnson, Merck, Pfizer and Portola Pharmaceuticals; receiving honoraria from AstraZeneca, Blueprint Medicines, Health Advances, Janssen Oncology, Novocure, Takeda and Targeted Oncology; serving in a consulting or advisory role for AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb/Celgene and Ikena Oncology; receiving research funding to Marmarelis’s institution from AstraZeneca, Lilly and Trizell; receiving travel, accommodations and expenses from Boehringer Ingelheim […]
Read moreSmokers Who Quit Before Age 45 Significantly Reduce Risk of Lung Cancer
Quitting smoking between ages 45-54 still reduces the risk of cancer by a significant 78%, while doing so between ages 55-64 cuts it by 56%. Titled, “Association of Smoking Initiation and Cessation Across the Life Course and Cancer Mortality Prospective Study of 410 000 US Adults,” the study of over 400,000 Americans, found that smokers are three times more likely to die of a tobacco-related cancer than nonsmokers. However, reported the researchers, quitting by age 45 reduces this risk by 89%, while for those who quit before they […]
Read moreHere are the winners of the INVEST Pitch Perfect contest
The MedCity INVEST Pitch Perfect contest saw some compelling presentations by four groups of entrepreneurs seeking to make a difference in healthcare. They addressed myriad pain points in care coordination, care delivery, the patient experience and improving the collection and analysis of data for clinical decision support. The conference was hosted in partnership with MHIN. Startups competed across four tracks. Teams of three judges evaluated startups on criteria that included completeness of overall plan, business idea, market opportunity, business model and the founder(s)’ experience. Here’s a look […]
Read moreMeta-analysis confirms benefit of quitting smoking at lung cancer diagnosis
medwireNews: Quitting smoking around the time of receiving a lung cancer diagnosis is associated with significantly improved overall survival (OS) than continuing smoking, shows a meta-analysis published in the Journal of Thoracic Oncology. Pooled analysis of data on more than 10,000 participants of 21 studies published in 1980–2021 showed a significant 29% reduction in the risk for death for those who did versus did not quit smoking at or around the time of diagnosis. The findings were consistent for non-small-cell and small-cell lung cancer patients, with smoking […]
Read more